Home > Healthcare > Biotechnology > Biotechnology R&D > Organs-on-chips Market

Organs-on-chips Market Share

Report ID: GMI7964
Published Date: Jan 2024
Report Format: PDF

Download Free Sample

Organs-on-chips Market Share

Leading organs-on-chips industry players are focusing on R&D, product innovation, and strategic collaborations to gain a competitive edge and meet the growing demand for advanced in-vitro models. These firms are also eyeing investments to proliferate their portfolio.

Organs-on-chips Market Companies

Prominent participants operating in the organs-on-chips industry are:

Altis Biosystems
AlveoliX AG
Axosim
Bi/ond Solutions B.V
Cherry Biotech
CN-Bio
Emulate, Inc.
Hesperos, Inc.
Insphero
MesoBioTech
Mimetas B.V.
Nortis Inc.
React4Life
TARA Biosystems (Valo Health)
TissUse GmbH

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Organs-on-chips market size crossed USD 116.5 million in 2023 and is expected to reach over USD 1.4 billion by 2032 owing to the increasing demand for more accurate and reliable in-vitro models of human organs for drug discovery, toxicity testing, and disease modelling worldwide.

Organs-on-chips industry from the polydimethylsiloxane (PDMS) segment is expected to reach USD 646.9 million by 2032 due to its compatibility with high-resolution microstructures and nanostructures through replica molding.

North America organs-on-chips industry reached USD 44.9 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to rising prevalence of chronic diseases in the region.

Altis Biosystems, AlveoliX AG, Axosim, Bi/ond Solutions B.V, Cherry Biotech, CN-Bio, Emulate, Inc., Hesperos, Inc., Insphero, MesoBioTech, Mimetas B.V., Nortis Inc., React4Life, TARA Biosystems (Valo Health), and TissUse GmbH, are some of the major organs-on-chips companies worldwide.